Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
62.75 USD | +1.92% | -6.34% | +237.18% |
May. 17 | Raymond James Upgrades Viking Therapeutics to Strong Buy From Outperform | MT |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
Business Summary
Number of employees: 28
Managers
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Michael Morneau
ADM | Chief Administrative Officer | 58 | 14-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Lawson Macartney
CHM | Chairman | 66 | 14-04-30 |
Brian Lian
FOU | Founder | 58 | 12-09-23 |
S. Rouan
BRD | Director/Board Member | 61 | 19-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 110,268,210 | 102,654,447 ( 93.10 %) | 0 | 93.10 % |
Company contact information
Viking Therapeutics, Inc.
9920 Pacific Heights Boulevard Suite 350
92121, San Diego
+858 704 4660
http://www.vikingtherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+237.18% | 6.92B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- VKTX Stock
- Company Viking Therapeutics, Inc.